அறிவியல் கல்லூரி ஆஃப் மருந்து News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from அறிவியல் கல்லூரி ஆஃப் மருந்து. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In அறிவியல் கல்லூரி ஆஃப் மருந்து Today - Breaking & Trending Today

Hare Leaps to New Role at Unity (Movers & Shakers)


Rick Hare of Unity Health in Searcy
Rick Hare has been promoted to assistant vice president of facility services at Unity Health in Searcy. Hare previously served as director of engineering for Unity Health for 27 years. He will be responsible for the growth of facilities in Searcy, Newport and Jacksonville.
Nancy J. Rusch of the University of Arkansas for Medical Sciences College of Medicine in Little Rock
Nancy J. Rusch has been named executive associate dean of research of the College of Medicine at the University of Arkansas for Medical Sciences in Little Rock. Rusch will continue to lead the college’s Department of Pharmacology & Toxicology, where she has worked since 2005. Rusch previously has served as president of the Cardiology Pharmacology Division of the American Society of Pharmacology & Experimental Therapeutics. ....

United States , University Of Arkansas , Little Rock , Nancyj Rusch , Unity Health , Sciences In Little Rock , Unity Health In Searcy , Department Of Pharmacology Toxicology , Sciences College Of Medicine , College Of Medicine , Hare Leaps , New Role , Arkansas Business , Rick Hare , Medical Sciences College , Medical Sciences , Cardiology Pharmacology Division , American Society , ஒன்றுபட்டது மாநிலங்களில் , பல்கலைக்கழகம் ஆஃப் ஆர்கன்சாஸ் , கொஞ்சம் பாறை , ஒற்றுமை ஆரோக்கியம் , அறிவியல் இல் கொஞ்சம் பாறை , ஒற்றுமை ஆரோக்கியம் இல் தேடல் , துறை ஆஃப் மருந்தியல் நச்சுயியல் , அறிவியல் கல்லூரி ஆஃப் மருந்து ,

Cancer DNA blood tests validated by international research t


Researchers have independently validated industry-leading blood tests that can detect the DNA released by tumours.
An international team today reports the findings of an independent assessment of five commercially-available assays for tumour DNA sequencing – a fast, cheap and less invasive method to diagnose and monitor cancer.
The researchers revealed that all assays could reliably detect so-called circulating tumour DNA (ctDNA) when it made up 0.5% of the total DNA in blood, a level of sensitivity that allows detection, genetic analysis and monitoring of late-stage and metastatic tumours.
Published in the journal Nature Biotechnology, the study is a major milestone for the use of ctDNA assays as cancer diagnostics, outlining best-practice guidelines and uncovering key areas of future development. ....

United States , Ira Deveson , Tim Mercer , Joshua Xu , Donald Johann Jr , Roche Sequencing Solutions , Garvan Institute , National Center , University Of Queensland , Australian Institute For , Toxicological Research , Garvan Institute Of Medical Research , Sciences College Of Medicine , University Of Arkansas , Nature Biotechnology , Medical Research , Sequencing Quality Control Phase , Thermo Fisher , Medical Sciences College , Biomedical Informatics , Associate Professor Tim Mercer , Australian Institute , Dna Sequencing , Cancer Screening , Cancer Mutations , Clinical Trials ,